Aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be an extremely potent cancer-fighter. The researchers created a hybrid of two earlier formulations, which they have called ‘NOSH-aspirin.’ The new designer aspirin curbed the growth of 11 different types of human cancer cells in culture without harming normal cells, reported a paper published this month in Medicinal Chemistry Letters. The ...
↧